Muscarinic Toxin 7 Signals Via Ca2+/Calmodulin-Dependent Protein Kinase Kinase β to Augment Mitochondrial Function and Prevent Neurodegeneration

Molecular Neurobiology - Tập 57 - Trang 2521-2538 - 2020
Ali Saleh1, Mohammad Golam Sabbir1, Mohamad-Reza Aghanoori1,2, Darrell R. Smith1, Subir K. Roy Chowdhury1, Lori Tessler1, Jennifer Brown1, Eva Gedarevich3, Markos Z. Kassahun3, Katie Frizzi3, Nigel A. Calcutt3, Paul Fernyhough1,2
1Division of Neurodegenerative Disorders, St Boniface Hospital Albrechtsen Research Centre, Winnipeg, Canada
2Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Canada
3Department of Pathology, University of California San Diego, La Jolla, USA

Tóm tắt

Mitochondrial dysfunction is implicated in a variety of neurodegenerative diseases of the nervous system. Peroxisome proliferator–activated receptor-γ coactivator-1α (PGC-1α) is a regulator of mitochondrial function in multiple cell types. In sensory neurons, AMP-activated protein kinase (AMPK) augments PGC-1α activity and this pathway is depressed in diabetes leading to mitochondrial dysfunction and neurodegeneration. Antimuscarinic drugs targeting the muscarinic acetylcholine type 1 receptor (M1R) prevent/reverse neurodegeneration by inducing nerve regeneration in rodent models of diabetes and chemotherapy-induced peripheral neuropathy (CIPN). Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ) is an upstream regulator of AMPK activity. We hypothesized that antimuscarinic drugs modulate CaMKKβ to enhance activity of AMPK, and PGC-1α, increase mitochondrial function and thus protect from neurodegeneration. We used the specific M1R antagonist muscarinic toxin 7 (MT7) to manipulate muscarinic signaling in the dorsal root ganglia (DRG) neurons of normal rats or rats with streptozotocin-induced diabetes. DRG neurons treated with MT7 (100 nM) or a selective muscarinic antagonist, pirenzepine (1 μM), for 24 h showed increased neurite outgrowth that was blocked by the CaMKK inhibitor STO-609 (1 μM) or short hairpin RNA to CaMKKβ. MT7 enhanced AMPK phosphorylation which was blocked by STO-609 (1 μM). PGC-1α reporter activity was augmented up to 2-fold (p < 0.05) by MT7 and blocked by STO-609. Mitochondrial maximal respiration and spare respiratory capacity were elevated after 3 h of exposure to MT7 (p < 0.05). Diabetes and CIPN induced a significant (p < 0.05) decrease in corneal nerve density which was corrected by topical delivery of MT7. We reveal a novel M1R-modulated, CaMKKβ-dependent pathway in neurons that represents a therapeutic target to enhance nerve repair in two of the most common forms of peripheral neuropathy.

Tài liệu tham khảo

Albers KM, Davis BM (2007) The skin as a neurotrophic organ. Neuroscientist 13(4):371–382. https://doi.org/10.1177/10738584070130040901

Taylor AM, Ribeiro-da-Silva A (2011) GDNF levels in the lower lip skin in a rat model of trigeminal neuropathic pain: implications for nonpeptidergic fiber reinnervation and parasympathetic sprouting. Pain 152(7):1502–1510. https://doi.org/10.1016/j.pain.2011.02.035

Bennett GJ, Doyle T, Salvemini D (2014) Mitotoxicity in distal symmetrical sensory peripheral neuropathies. Nat Rev Neurol 10(6):326–336. https://doi.org/10.1038/nrneurol.2014.77

Cashman CR, Hoke A (2015) Mechanisms of distal axonal degeneration in peripheral neuropathies. Neurosci Lett 596:33–50. https://doi.org/10.1016/j.neulet.2015.01.048

Vinik AI, Casellini C, Nevoret ML (2016) Alternative quantitative tools in the assessment of diabetic peripheral and autonomic neuropathy. Int Rev Neurobiol 127:235–285. https://doi.org/10.1016/bs.irn.2016.03.010

Malik RA (2016) Wherefore art thou, O treatment for diabetic neuropathy? Int Rev Neurobiol 127:287–317. https://doi.org/10.1016/bs.irn.2016.03.008

Lauria G, Morbin M, Lombardi R, Borgna M, Mazzoleni G, Sghirlanzoni A, Pareyson D (2003) Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 61(5):631–636

Schmidt RE (2002) Neuropathology and pathogenesis of diabetic autonomic neuropathy. Int Rev Neurobiol 50:257–292

Zherebitskaya E, Akude E, Smith DR, Fernyhough P (2009) Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 58(6):1356–1364

Zochodne DW (2016) Sensory neurodegeneration in diabetes: beyond glucotoxicity. Int Rev Neurobiol 127:151–180. https://doi.org/10.1016/bs.irn.2016.03.007

Zochodne DW (2015) Diabetes and the plasticity of sensory neurons. Neurosci Lett 596:60–65. https://doi.org/10.1016/j.neulet.2014.11.017

Christianson JA, Ryals JM, Johnson MS, Dobrowsky RT, Wright DE (2007) Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 145(1):303–313. https://doi.org/10.1016/j.neuroscience.2006.11.064

Jolivalt CG, Lee CA, Ramos KM, Calcutt NA (2008) Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain 140(1):48–57. https://doi.org/10.1016/j.pain.2008.07.005

Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470. https://doi.org/10.1016/j.pain.2014.09.020

Bernstein BW, Bamburg JR (2003) Actin-ATP hydrolysis is a major energy drain for neurons. J Neurosci 23(1):1–6

Wang SS, Shultz JR, Burish MJ, Harrison KH, Hof PR, Towns LC, Wagers MW, Wyatt KD (2008) Functional trade-offs in white matter axonal scaling. J Neurosci 28(15):4047–4056. https://doi.org/10.1523/JNEUROSCI.5559-05.2008

Chen H, Chan DC (2006) Critical dependence of neurons on mitochondrial dynamics. Curr Opin Cell Biol 18(4):453–459. https://doi.org/10.1016/j.ceb.2006.06.004

Mironov SL (2007) ADP regulates movements of mitochondria in neurons. Biophys J 92(8):2944–2952. https://doi.org/10.1529/biophysj.106.092981

Kruger L, Perl ER, Sedivec MJ (1981) Fine structure of myelinated mechanical nociceptor endings in cat hairy skin. J Comp Neurol 198(1):137–154. https://doi.org/10.1002/cne.901980112

Ribeiro-da-Silva A, Kenigsberg RL, Cuello AC (1991) Light and electron microscopic distribution of nerve growth factor receptor-like immunoreactivity in the skin of the rat lower lip. Neuroscience 43(2–3):631–646

Fernyhough P (2015) Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events. Curr Diab Rep 15(11):89. https://doi.org/10.1007/s11892-015-0671-9

Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG (2005) Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2(1):9–19. https://doi.org/10.1016/j.cmet.2005.05.009

Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D (2005) Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2(1):21–33. https://doi.org/10.1016/j.cmet.2005.06.005

Green MF, Anderson KA, Means AR (2011) Characterization of the CaMKKbeta-AMPK signaling complex. Cell Signal 23(12):2005–2012. https://doi.org/10.1016/j.cellsig.2011.07.014

Feige JN, Auwerx J (2007) Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol 17(6):292–301. https://doi.org/10.1016/j.tcb.2007.04.001

Hardie DG (2008) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32 Suppl 4:S7–12. doi:https://doi.org/10.1038/ijo.2008.116

Marcelo KL, Means AR, York B (2016) The Ca2+/calmodulin/CaMKK2 axis: nature’s metabolic CaMshaft. Trends Endocrinol Metab 27(10):706–718. https://doi.org/10.1016/j.tem.2016.06.001

Akude E, Zherebitskaya E, Chowdhury SK, Smith DR, Dobrowsky RT, Fernyhough P (2011) Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats. Diabetes 60(1):288–297. https://doi.org/10.2337/db10-0818

Roy Chowdhury SK, Smith DR, Saleh A, Schapansky J, Marquez A, Gomes S, Akude E, Morrow D et al (2012) Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain 135(Pt 6):1751–1766. https://doi.org/10.1093/brain/aws097

Ma J, Farmer KL, Pan P, Urban MJ, Zhao H, Blagg BS, Dobrowsky RT (2014) Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and reverse diabetic sensory neuropathy following KU-32 therapy. J Pharmacol Exp Ther 348(2):281–292. https://doi.org/10.1124/jpet.113.210435

Urban MJ, Pan P, Farmer KL, Zhao H, Blagg BS, Dobrowsky RT (2012) Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy. Exp Neurol 235(1):388–396. https://doi.org/10.1016/j.expneurol.2012.03.005

Kalichman MW, Powell HC, Mizisin AP (1998) Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol 95(1):47–56

Kamiya H, Zhang W, Sima AA (2006) Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats. Diabetologia 49(11):2763–2774. https://doi.org/10.1007/s00125-006-0379-0

Brown DA, Passmore GM (2009) Neural KCNQ (Kv7) channels. Br J Pharmacol 156(8):1185–1195. https://doi.org/10.1111/j.1476-5381.2009.00111.x

Tata AM, Cursi S, Biagioni S, Augusti-Tocco G (2003) Cholinergic modulation of neurofilament expression and neurite outgrowth in chick sensory neurons. J Neurosci Res 73(2):227–234. https://doi.org/10.1002/jnr.10650

Yang H, Kunes S (2004) Nonvesicular release of acetylcholine is required for axon targeting in the Drosophila visual system. Proc Natl Acad Sci U S A 101(42):15213–15218. https://doi.org/10.1073/pnas.0308141101

Erskine L, McCaig CD (1995) Growth cone neurotransmitter receptor activation modulates electric field-guided nerve growth. Dev Biol 171(2):330–339. https://doi.org/10.1006/dbio.1995.1285

Bernardini N, Levey AI, Augusti-Tocco G (1999) Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins. J Peripher Nerv Syst 4(3–4):222–232

Grando SA, Pittelkow MR, Schallreuter KU (2006) Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J Invest Dermatol 126(9):1948–1965. https://doi.org/10.1038/sj.jid.5700151

Bellier JP, Kimura H (2007) Acetylcholine synthesis by choline acetyltransferase of a peripheral type as demonstrated in adult rat dorsal root ganglion. J Neurochem 101(6):1607–1618. https://doi.org/10.1111/j.1471-4159.2007.04458.x

Hanada K, Kishimoto S, Bellier JP, Kimura H (2013) Peripheral choline acetyltransferase in rat skin demonstrated by immunohistochemistry. Cell Tissue Res 351(3):497–510. https://doi.org/10.1007/s00441-012-1536-z

Calcutt NA, Smith DR, Frizzi K, Sabbir MG, Chowdhury SK, Mixcoatl-Zecuatl T, Saleh A, Muttalib N et al (2017) Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy. J Clin Invest 127(2):608–622. https://doi.org/10.1172/JCI88321

Sabbir MG, Calcutt NA, Fernyhough P (2018) Muscarinic acetylcholine type 1 receptor activity constrains neurite outgrowth by inhibiting microtubule polymerization and mitochondrial trafficking in adult sensory neurons. Front Neurosci 12:402. https://doi.org/10.3389/fnins.2018.00402

Sabbir MG, Fernyhough P (2018) Muscarinic receptor antagonists activate ERK-CREB signaling to augment neurite outgrowth of adult sensory neurons. Neuropharmacology 143:268–281. https://doi.org/10.1016/j.neuropharm.2018.09.020

Max SI, Liang JS, Potter LT (1993) Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol Pharmacol 44(6):1171–1175

Gaff J, Octaviana F, Ariyanto I, Cherry C, Laws SM, Price P (2019) Polymorphisms in CAMKK2 associate with susceptibility to sensory neuropathy in HIV patients treated without stavudine. J Neuro-Oncol 25:814–824. https://doi.org/10.1007/s13365-019-00771-w

Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR (1996) Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 68(2–3):293–299

Marshall AG, Lee-Kubli C, Azmi S, Zhang M, Ferdousi M, Mixcoatl-Zecuatl T, Petropoulos IN, Ponirakis G et al (2017) Spinal disinhibition in experimental and clinical painful diabetic neuropathy. Diabetes 66(5):1380–1390. https://doi.org/10.2337/db16-1181

Galbraith JA, Mrosko BJ, Myers RR (1993) A system to measure thermal nociception. J Neurosci Methods 49(1–2):63–68. https://doi.org/10.1016/0165-0270(93)90109-5

Smith DS, Skene JH (1997) A transcription-dependent switch controls competence of adult neurons for distinct modes of axon growth. J Neurosci 17(2):646–658

Green MF, Scott JW, Steel R, Oakhill JS, Kemp BE, Means AR (2011) Ca2+/calmodulin-dependent protein kinase kinase beta is regulated by multisite phosphorylation. J Biol Chem 286(32):28066–28079. https://doi.org/10.1074/jbc.M111.251504

Saleh A, Shan L, Halayko AJ, Kung S, Gounni AS (2009) Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells. J Immunol 182(6):3357–3365

Sabbir MG (2018) Loss of Ca2+/calmodulin dependent protein kinase kinase 2 leads to aberrant transferrin phosphorylation and trafficking: a potential biomarker for Alzheimer’s disease. Front Mol Biosci 5:99. https://doi.org/10.3389/fmolb.2018.00099

Rungta RL, Choi HB, Lin PJ, Ko RW, Ashby D, Nair J, Manoharan M, Cullis PR et al (2013) Lipid nanoparticle delivery of siRNA to silence neuronal gene expression in the brain. Mol Ther Nucleic Acids 2:e136. https://doi.org/10.1038/mtna.2013.65

Chowdhury SK, Zherebitskaya E, Smith DR, Akude E, Chattopadhyay S, Jolivalt CG, Calcutt NA, Fernyhough P (2010) Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. Diabetes 59(4):1082–1091. https://doi.org/10.2337/db09-1299

Jolivalt CG, Frizzi KE, Guernsey L, Marquez A, Ochoa J, Rodriguez M, Calcutt NA (2016) Peripheral neuropathy in mouse models of diabetes. Curr Protoc Mouse Biol 6(3):223–255. https://doi.org/10.1002/cpmo.11

Chen DK, Frizzi KE, Guernsey LS, Ladt K, Mizisin AP, Calcutt NA (2013) Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst 18(4):306–315. https://doi.org/10.1111/jns5.12044

Jolivalt CG, Marquez A, Quach D, Navarro Diaz MC, Anaya C, Kifle B, Muttalib N, Sanchez G et al (2019) Amelioration of both central and peripheral neuropathy in mouse models of type 1 and type 2 diabetes by the neurogenic molecule NSI-189. Diabetes 68(11):2143–2154. https://doi.org/10.2337/db19-0271

Nakamuta S, Funahashi Y, Namba T, Arimura N, Picciotto MR, Tokumitsu H, Soderling TR, Sakakibara A et al (2011) Local application of neurotrophins specifies axons through inositol 1,4,5-trisphosphate, calcium, and Ca2+/calmodulin-dependent protein kinases. Sci Signal 4(199):ra76. https://doi.org/10.1126/scisignal.2002011

Cao W, Sohail M, Liu G, Koumbadinga GA, Lobo VG, Xie J (2011) Differential effects of PKA-controlled CaMKK2 variants on neuronal differentiation. RNA Biol 8(6):1061–1072. https://doi.org/10.4161/rna.8.6.16691

Wayman GA, Kaech S, Grant WF, Davare M, Impey S, Tokumitsu H, Nozaki N, Banker G et al (2004) Regulation of axonal extension and growth cone motility by calmodulin-dependent protein kinase I. J Neurosci 24(15):3786–3794. https://doi.org/10.1523/JNEUROSCI.3294-03.2004

Duan J, Cui J, Yang Z, Guo C, Cao J, Xi M, Weng Y, Yin Y et al (2019) Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3beta/Nrf2 signaling. J Neuroinflammation 16(1):24. https://doi.org/10.1186/s12974-019-1406-7

Zhang Y, Xu N, Ding Y, Doycheva DM, Zhang Y, Li Q, Flores J, Haghighiabyaneh M et al (2019) Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic-ischemic encephalopathy. Cell Death Dis 10(2):97. https://doi.org/10.1038/s41419-019-1374-y

Dasgupta B, Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A 104(17):7217–7222. https://doi.org/10.1073/pnas.0610068104

Schartner E, Sabbir MG, Saleh A, Silva RV, Roy Chowdhury S, Smith DR, Fernyhough P (2018) High glucose concentration suppresses a SIRT2 regulated pathway that enhances neurite outgrowth in cultured adult sensory neurons. Exp Neurol 309:134–147. https://doi.org/10.1016/j.expneurol.2018.08.001

Bugger H, Abel ED (2010) Mitochondria in the diabetic heart. Cardiovasc Res 88(2):229–240. https://doi.org/10.1093/cvr/cvq239

Gao AW, Canto C, Houtkooper RH (2014) Mitochondrial response to nutrient availability and its role in metabolic disease. EMBO Mol Med 6(5):580–589. https://doi.org/10.1002/emmm.201303782

Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267–273. https://doi.org/10.1038/ng1180ng1180

Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I et al (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100(14):8466–8471. https://doi.org/10.1073/pnas.10329131001032913100

Richardson DK, Kashyap S, Bajaj M, Cusi K, Mandarino SJ, Finlayson J, DeFronzo RA, Jenkinson CP et al (2005) Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 280(11):10290–10297. https://doi.org/10.1074/jbc.M408985200

Szendroedi J, Phielix E, Roden M (2012) The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 8(2):92–103. https://doi.org/10.1038/nrendo.2011.138

Dugan LL, You YH, Ali SS, Diamond-Stanic M, Miyamoto S, DeCleves AE, Andreyev A, Quach T et al (2013) AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest 123(11):4888–4899. https://doi.org/10.1172/JCI66218

Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA et al (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. EMBO J 26(13):3169–3179. https://doi.org/10.1038/sj.emboj.7601758

St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K et al (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127(2):397–408. https://doi.org/10.1016/j.cell.2006.09.024

Tsunemi T, La Spada AR (2012) PGC-1alpha at the intersection of bioenergetics regulation and neuron function: from Huntington’s disease to Parkinson’s disease and beyond. Prog Neurobiol 97(2):142–151. https://doi.org/10.1016/j.pneurobio.2011.10.004

Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, Troconso JC, Dawson VL et al (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson’s disease. Cell 144(5):689–702. https://doi.org/10.1016/j.cell.2011.02.010

Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF et al (2005) PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3(4):e101. https://doi.org/10.1371/journal.pbio.0030101

Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jager S et al (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119(1):121–135. https://doi.org/10.1016/j.cell.2004.09.013

Quattrini C, Tavakoli M, Jeziorska M, Kallinikos P, Tesfaye S, Finnigan J, Marshall A, Boulton AJ et al (2007) Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56(8):2148–2154. https://doi.org/10.2337/db07-0285

Ferdousi M, Azmi S, Petropoulos IN, Fadavi H, Ponirakis G, Marshall A, Tavakoli M, Malik I et al (2015) Corneal confocal microscopy detects small fibre neuropathy in patients with upper gastrointestinal cancer and nerve regeneration in chemotherapy induced peripheral neuropathy. PLoS One 10(10):e0139394. https://doi.org/10.1371/journal.pone.0139394

Petropoulos IN, Ponirakis G, Khan A, Gad H, Almuhannadi H, Brines M, Cerami A, Malik RA (2019) Corneal confocal microscopy: ready for prime time. Clin Exp Optom. https://doi.org/10.1111/cxo.12887

Rohacs T (2014) Phosphoinositide regulation of TRP channels. Handb Exp Pharmacol 223:1143–1176. https://doi.org/10.1007/978-3-319-05161-1_18

Nilius B, Owsianik G (2011) The transient receptor potential family of ion channels. Genome Biol 12(3):218. https://doi.org/10.1186/gb-2011-12-3-218

Toth BI, Konrad M, Ghosh D, Mohr F, Halaszovich CR, Leitner MG, Vriens J, Oberwinkler J et al (2015) Regulation of the transient receptor potential channel TRPM3 by phosphoinositides. J Gen Physiol 146(1):51–63. https://doi.org/10.1085/jgp.201411339

Badheka D, Rohacs T (2015) TRPM3 joins the ranks of PI(4,5)P2 sensitive ion channels. Channels (Austin) 9(5):233–234. https://doi.org/10.1080/19336950.2015.1089072

Straub I, Krugel U, Mohr F, Teichert J, Rizun O, Konrad M, Oberwinkler J, Schaefer M (2013) Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo. Mol Pharmacol 84(5):736–750. https://doi.org/10.1124/mol.113.086843

Vriens J, Owsianik G, Hofmann T, Philipp SE, Stab J, Chen X, Benoit M, Xue F et al (2011) TRPM3 is a nociceptor channel involved in the detection of noxious heat. Neuron 70(3):482–494. https://doi.org/10.1016/j.neuron.2011.02.051

Holendova B, Grycova L, Jirku M, Teisinger J (2012) PtdIns(4,5)P2 interacts with CaM binding domains on TRPM3 N-terminus. Channels (Austin) 6(6):479–482. https://doi.org/10.4161/chan.22177

Holakovska B, Grycova L, Jirku M, Sulc M, Bumba L, Teisinger J (2012) Calmodulin and S100A1 protein interact with N terminus of TRPM3 channel. J Biol Chem 287(20):16645–16655. https://doi.org/10.1074/jbc.M112.350686

Chauhan AS, Liu X, Jing J, Lee H, Yadav RK, Liu J, Zhou Y, Gan B (2019) STIM2 interacts with AMPK and regulates calcium-induced AMPK activation. FASEB J 33(2):2957–2970. https://doi.org/10.1096/fj.201801225R

Thông tin
Thông tin xuất bản

Molecular Neurobiology

Tập 57

2521-2538

Thông tin tác giả